Best 3 Nuclear Energy Stocks to Buy Right Now

Vistra secured a 2,600 MW, 20-year nuclear power supply deal with Meta and is hosting Amazon's planned data center on a Vistra nuclear site, highlighting commercial demand for nuclear power from data centers. Cameco sold 21 million pounds of uranium last year, generating about $3.5B in revenue and ~$600M net income, and stands to benefit from projected uranium demand rising from ~70,000 metric tons to ~150,000 metric tons by 2040. NuScale's 77-MW SMR is the only NRC-approved design and has a 12-month analyst target of $18.68 (+60% vs. current), though the company remains unprofitable and higher risk.

Analysis

Nuclear's re-acceleration creates a split alpha opportunity: upstream physical suppliers and midstream chokepoints (conversion, enrichment, fuel fabrication, and specialty forgings) will see near-term margin tailwinds because mine lead-times and capacity expansion are multi-year. Buyers that need firm, 24/7 baseload (AI/data centers) will increasingly pay for contract certainty — that shifts value from merchant generators toward firms that can deliver long-dated, location-specific power and firming services.

SMRs change the geography of demand: modularization compresses site risk but magnifies serial-production and supply-chain risk — the economics depend on achieving multi-unit factory cadence and large forgings/heat-exchanger throughput, not just reactor design. Expect an uneven roll-out where first-of-a-kind projects face 30–50% cost and schedule overrun risk, while the second wave (3–8 years out) is where unit costs can actually bend down.

Key near-term catalysts are inventory draws and term-contract tenders (months–18 months), regulatory licensing and first concrete pours (12–36 months), and serial factory commitments (3–7 years). Tail risks that would unwind the trade are rapid LDES breakthroughs or a geopolitical flood of secondary uranium (e.g., accelerated civilian down-blending or large government releases), both of which would re-price term curves within quarters.

The consensus underestimates the asymmetric payoff between physical suppliers and reactor developers: commodity producers benefit from structural scarcity and long-term offtakes; reactor developers carry binary execution risk. Position sizing should reflect that divergence — play physical and midstream chokepoints with core allocations, keep SMR exposure tactical and option-led until repeatable modular production is demonstrated.

Key Decisions for Investors

• Core long (12–24 months): Buy upstream uranium exposure (CCJ) as a 3–4% portfolio allocation via a 12-month call spread to cap downside; target 30–50% return if term curve firming continues, stop if term contract activity stalls for two consecutive quarters.
• Pair trade (6–18 months): Long utilities/wholesalers with proven site control (VST) vs short broad merchant power/renewable pure-plays — size 2% net long VST financed by 1% short of a levered renewable ETF; thesis: secured long-term PPAs re-rate asset-level multiples, downside if PPAs are renegotiated.
• Tactical option play (18–36 months): Buy SMR exposure (SMR) with small allocation (1% portfolio) using LEAP calls or long-dated call spreads to capture upside if serial production commitments materialize; cap loss to premium paid, expect high volatility and binary outcomes.
• Hedge / contrarian (rolling 12 months): Buy protection via a uranium-term-curve hedge or long physical-linked ETF if available, or short a small amount of reactor-developer equities without factory commitments — hedge size 25–35% of long physical exposure to protect vs execution failures.
• Watchlist triggers: Increase upstream exposure on confirmed large utility/data-center PPA announcements or government strategic purchases (add 1–2% per confirmed 1 GW+ PPA); reduce SMR option exposure if two consecutive projects miss commercial milestones.